Skip to main content

Table 2 Socio-demographic factors, medical history and oral HPV infection among Indian HIV-positive MSM (N = 295)

From: Prevalence of oral human papillomavirus infection among Indian HIV-positive men who have sex with men: a cross-sectional study

 

No Oral HPV infection

Oral HPV Infection

 

Characteristic

N

(%)

N

(%)

P-valued

OR (95% CI)d

Total N

225

(76)

70

(24)

  

Study Site

    

0.2604

 

 CMC, Vellore

117

(79)

31

(21)

 

1.0

 HT, Mumbai

108

(73)

39

(27)

 

1.4 (0.8–2.3)

Age Categoriesa

    

0.5064

 

 18–25

33

(79)

9

(21)

 

1.0

 26–35

92

(79)

24

(21)

 

1.0 (0.4–2.3)

 35+

93

(73)

34

(27)

 

1.3 (0.6–3.1)

Highest number of years of school completed

    

0.7635

 

 None

40

(80)

10

(20)

 

1.0

 1–10

145

(76)

46

(24)

 

1.3 (0.6–2.7)

 10+

40

(74)

14

(26)

 

1.4 (0.6–3.5)

Monthly income (mean ± SD)

4268

(±4128)

5621

(±6320)

0.0970

1.0 (1.0–1.0)

Religion

    

0.4865

 

 Hindu

175

(75)

58

(25)

 

1.0

 Muslim

31

(77)

9

(23)

 

0.9 (0.4–1.9)

 Other

19

(86)

3

(14)

 

0.5 (0.1–1.7)

Marital Status

  

.

 

0.9519

 

 Unmarried

118

(76)

37

(24)

 

1.0

 Married

107

(76)

33

(24)

 

1.0 (0.6–1.7)

Smoked more than 100 lifetime cigarettes

  

.

 

0.5269

 

 No

160

(77)

47

(23)

 

1.0

 Yes

65

(74)

23

(26)

 

1.2 (0.7–2.1)

Mean years smoked

4

(±8)

4

(±7)

0.8550

1.0 (1.0–1.0)

Chews tobacco ‘regularly’b

  

.

 

0.0077

 

 No

145

(72)

57

(28)

 

1.0

 Yes

80

(86)

13

(14)

 

0.4 (0.2–0.8)

 If Yes: How often chew tobacco on average per week

    

0.0709

 

   < 2 days/week

22

(100)

0

(0)

 

NE

  3–5 days/week

9

(90)

1

(10)

 

1.0

  6–7 days/week

49

(80)

12

(20)

 

7.6 (0.9–61.3)e

Consumes alcohol

    

0.2531

 

 No

95

(73)

35

(27)

 

1.0

 Yes

130

(79)

35

(21)

 

0.7 (0.4–1.3)

CD4 (cells/uL)c

  

.

 

0.0106

 

  < 200

21

(57)

16

(43)

 

3.1 (1.4–6.9)

 200–500

113

(78)

31

(22)

 

1.1 (0.6–2.0)

 500+

89

(80)

22

(20)

 

1.0

HIV viral loadc

  

.

 

0.4570

 

 Undetectable

77

(73)

28

(27)

 

1.0

  > 400–37,400

72

(81)

17

(19)

 

0.6 (0.3–1.3)

  > 37,400

75

(76)

24

(24)

 

0.9 (0.5–1.7)

Antiretroviral therapy use

    

0.2227

 

 No

128

(79)

34

(21)

 

1.0

 Yes

97

(73)

36

(27)

 

1.4 (0.8–2.4)

  1. a Indicates 1–5% of participant data were missing
  2. b ‘regularly’ was not defined to participants but was translated into Hindi and Tamil, with the back translation of “regularly” or “often”
  3. c Indicates 1–2 individual participant data were missing
  4. d p-value for categorical variable from chi-square, and from ANOVA or ranked ANOVA for normally and non-normally distributed continuous variables. Odds ratio (OR) and 95% confidence interval (CI) from unadjusted logistic regression model
  5. e comparison between participants who reported 2–5 days a week and 6–7 days a week. Participants with < 2 days a week were omitted from this calculation